Lumosa Therapeutics , Ltd. Intangible Assets

Lumosa Therapeutics , Ltd. (6535.TWO) currently reports a intangible assets of $310K as of June 2026. That compares with $430K in the prior-year period — down 27.3% year over year. Use the charts on this page to explore Lumosa Therapeutics , Ltd.'s intangible assets history and peer comparisons.

Lumosa Therapeutics , Ltd.'s intangible assets decreased from $430K to $310K — a 27.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lumosa Therapeutics , Ltd. reported $310K in intangible assets as of June 2026. That compares with $430K in the prior-year period — down 27.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $310K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lumosa Therapeutics , Ltd., and consider following 6535.TWO for alerts when major investors trade the stock.

Lumosa Therapeutics , Ltd. is classified in the Healthcare sector. On intangible assets, it currently shows $310K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6535.TWO with unrelated industries.